Skip to main content

Advertisement

Articles

Page 3 of 44

  1. Content type: Research

    The human ether a-go-go-related gene 1 (HERG1) is involved in tumor progression; however, its role in esophageal squamous cell carcinoma (ESCC) is not well studied. This study investigated HERG1 function in ES...

    Authors: Hongqiang Wang, Xuchun Yang, Yan Guo, Lin Shui, Shi Li, Yifeng Bai, Yu Liu, Ming Zeng and Jianling Xia

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:324

    Published on:

  2. Content type: Review

    Numerous studies have presented that curcumin could have a positive effect in the prevention of cancer and then in tumor therapy. Several hypotheses have highlighted that curcumin could decreases tumor growth ...

    Authors: Alexandre Vallée, Yves Lecarpentier and Jean-Noël Vallée

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:323

    Published on:

  3. Content type: Research

    Recurrence and metastasis are the leading causes of tumour-related death in patients with oesophageal squamous cell carcinoma (ESCC). Tumour-infiltrating natural killer cells (NK cells) display powerful cytoto...

    Authors: Jian Wu, Feng-xia Gao, Chao Wang, Mei Qin, Fei Han, Tao Xu, Zhi Hu, Yang Long, Xue-mei He, Xin Deng, De-lian Ren and Tian-yang Dai

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:321

    Published on:

  4. Content type: Research

    Acquired resistance remains a limitation of the clinical use of 5-fluorouracil (5-FU). Because exosomes, are important vesicles participating in intercellular communication, their contribution to the developme...

    Authors: Qian Zhang, Rui-Xian Liu, Ka-Wo Chan, Jiancong Hu, Jingdan Zhang, Lili Wei, Huiliu Tan, Xiangling Yang and Huanliang Liu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:320

    Published on:

  5. Content type: Research

    Despite a good and overall prognosis, papillary thyroid cancer (PTC) can still affect the quality of life of many patients, and can even be life-threatening due to its invasiveness and metastasis. Emerging stu...

    Authors: Yao Yao, Xinyuan Chen, Hong Yang, Wei Chen, Yichun Qian, Zhongyi Yan, Tian Liao, Weiping Yao, Wenlan Wu, Tonghua Yu, Yun Chen and Yuan Zhang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:318

    Published on:

  6. Content type: Research

    Molecular markers for prostate cancer (PCa) are required to improve the early definition of patient outcomes. Atypically large extracellular vesicles (EVs), referred as “Large Oncosomes” (LO), have been identi...

    Authors: Chiara Ciardiello, Alessandra Leone, Paola Lanuti, Maria S. Roca, Tania Moccia, Valentina R. Minciacchi, Michele Minopoli, Vincenzo Gigantino, Rossella De Cecio, Massimo Rippa, Lucia Petti, Francesca Capone, Carlo Vitagliano, Maria R. Milone, Biagio Pucci, Rita Lombardi…

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:317

    Published on:

  7. Content type: Research

    Sorafenib is the first-line treatment for advanced-stage hepatocellular carcinoma (HCC). Several studies have shown that the up-regulation of β-catenin plays a role in sorafenib resistance in HCC; however, the...

    Authors: Ling Deng, Jingyuan Sun, Xiaohui Chen, Li Liu and Dehua Wu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:316

    Published on:

  8. Content type: Research

    Adenosine deaminases acting on RNA (ADARs) are involved in adenosine-to-inosine (A-to-I) editing and implicated in tumorigenesis and prognosis. Emerging evidence has indicated that ADAR1, an ADAR family member...

    Authors: Xue Liu, Yu Fu, Jiadong Huang, Meng Wu, Zhenxing Zhang, Rongyao Xu, Ping Zhang, Shouwei Zhao, Laikui Liu and Hongbing Jiang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:315

    Published on:

  9. Content type: Research

    IDO1 (Indoleamine 2,3-dioxygenase 1) inhibits host anti-tumor immune response by exhausting tryptophan in tumor microenvironment, but the pathogenic mechanisms of IDO1 in gastric cancer (GC) cells need to be f...

    Authors: Zhen Xiang, Jun Li, Shuzheng Song, Jiexuan Wang, Wei Cai, Wenjun Hu, Jun Ji, Zhenggang Zhu, Lu Zang, Ranlin Yan and Yingyan Yu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:314

    Published on:

  10. Content type: Research

    Breast cancer is the most common malignancy in women worldwide. Among the breast cancer subtypes, triple-negative breast cancer (TNBC) is the most aggressive and the most difficult to treat. One of the master ...

    Authors: Rossella Zanin, Silvia Pegoraro, Gloria Ros, Yari Ciani, Silvano Piazza, Fleur Bossi, Roberta Bulla, Cristina Zennaro, Federica Tonon, Dejan Lazarevic, Elia Stupka, Riccardo Sgarra and Guidalberto Manfioletti

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:313

    Published on:

  11. Content type: Research

    Glioblastoma is the most aggressive and most lethal primary brain tumor in the adulthood. Current standard therapies are not curative and novel therapeutic options are urgently required. Present knowledge sugg...

    Authors: F. Berardinelli, M. Tanori, D. Muoio, M. Buccarelli, A. di Masi, S. Leone, L. Ricci-Vitiani, R. Pallini, M. Mancuso and A. Antoccia

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:311

    Published on:

  12. Content type: Research

    Exosomes from cancer cells or immune cells, carrying bio-macromolecules or microRNAs (miRNAs), participate in tumor pathogenesis and progression by modulating microenvironment. Our study aims to investigate th...

    Authors: Zi Yin, Tingting Ma, Bowen Huang, Lehang Lin, Yu Zhou, Jinhai Yan, Yiping Zou and Sheng Chen

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:310

    Published on:

  13. Content type: Research

    Triple negative breast cancer (TNBC) is a breast cancer subgroup characterized by a lack of hormone receptors’ expression and no HER2 overexpression. These molecular features both drastically reduce treatment ...

    Authors: Matilde Clarissa Malfatti, Lorenzo Gerratana, Emiliano Dalla, Miriam Isola, Giuseppe Damante, Carla Di Loreto, Fabio Puglisi and Gianluca Tell

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:309

    Published on:

  14. Content type: Research

    At present, it is generally believed that leukemia stem cells are the source of AML, so the killing of leukemia stem cells has become important. Previous studies have suggested that HHT combined with ATO can s...

    Authors: Ming Tan, Qian Zhang, Xiaohong Yuan, Yuanzhong Chen and Yong Wu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:308

    Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2019 38:407

  15. Content type: Research

    We reported previously that phenethyl isothiocyanate (PEITC), a dietary compound, can reactivate p53R175H mutant in vitro and in SK-BR-3 (p53R175H) breast xenograft model resulting in tumor inhibition. Because of...

    Authors: Monika Aggarwal, Rahul Saxena, Nasir Asif, Elizabeth Sinclair, Judy Tan, Idalia Cruz, Deborah Berry, Bhaskar Kallakury, Quynhchi Pham, Thomas T. Y. Wang and Fung-Lung Chung

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:307

    Published on:

  16. Content type: Research

    HER2-overexpressing metastatic breast cancers are challenging practice in oncology when they become resistant to anti-HER2 therapies such as trastuzumab. In these clinical situations, HER2-overexpression persi...

    Authors: Toni Nunes, Thomas Pons, Xue Hou, Khanh Van Do, Benoît Caron, Marthe Rigal, Mélanie Di Benedetto, Bruno Palpant, Christophe Leboeuf, Anne Janin and Guilhem Bousquet

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:306

    Published on:

  17. Content type: Research

    The mechanism underlying breast cancer stem cell (BCSCs) characteristics remains to be fully elucidated. Accumulating evidence implies that long noncoding RNAs (lncRNAs) play a pivotal role in regulating BCSCs...

    Authors: Ang Zheng, Xinyue Song, Lin Zhang, Lin Zhao, Xiaoyun Mao, Minjie Wei and Feng Jin

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:305

    Published on:

  18. Content type: Research

    Esophageal squamous cell carcinoma (ESCC) is the most difficult subtype of esophageal cancer to treat due to the paucity of effective targeted therapy. ESCC is believed to arise from cancer stem cells (CSCs) t...

    Authors: Yue Zhao, Ji Zhu, Bowen Shi, Xinyu Wang, Qijue Lu, Chunguang Li and Hezhong Chen

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:304

    Published on:

  19. Content type: Research

    Gut microbiota and the tumor microenvironment are thought to be critical factors that modulate the processes of liver diseases, including hepatocellular carcinoma (HCC). Interleukin-25 (IL-25) promotes type 2 ...

    Authors: Qiao Li, Lei Ma, Shunli Shen, Yu Guo, Qinghua Cao, Xiuqin Cai, Juan Feng, Yuan Yan, Tianyu Hu, Shiya Luo, Lin Zhou, Baogang Peng, Zhonghan Yang and Yunpeng Hua

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:303

    Published on:

  20. Content type: Research

    Diabetes is recognized to be a risk factor of pancreatic cancer, but the mechanism has not been fully elucidated. Sterol regulatory element binding protein 1 (SREBP1) is an important transcription factor invol...

    Authors: Cancan Zhou, Weikun Qian, Jie Li, Jiguang Ma, Xin Chen, Zhengdong Jiang, Liang Cheng, Wanxing Duan, Zheng Wang, Zheng Wu, Qingyong Ma and Xuqi Li

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:302

    Published on:

  21. Content type: Research

    Colorectal cancer (CRC) remains the fourth most common cause of cancer-related mortality worldwide. We aimed to identify key molecules and signalling pathways mediating CRC growth and metastasis. Polypyrimidin...

    Authors: Pingfu Hou, Fang Chen, Hongmei Yong, Tian Lin, Jingjing Li, Yu Pan, Tao Jiang, Minle Li, Yansu Chen, Jun Song, Junnian Zheng and Jin Bai

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:301

    Published on:

  22. Content type: Research

    Cancer is fundamentally a deregulation of cell growth and proliferation. Cancer cells often have perturbed metabolism that leads to the alteration of metabolic intermediates. Dehydrogenase/reductase member 2 (...

    Authors: Xiangjian Luo, Namei Li, Xu Zhao, Chaoliang Liao, Runxin Ye, Can Cheng, Zhijie Xu, Jing Quan, Jikai Liu and Ya Cao

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:300

    Published on:

  23. Content type: Research

    Programmed death 1 (PD-1) blockade has great effect in the prevention of oral precancerous lesions, but the drug resistance has also been observed. The determinants of immune resistance during the malignant tr...

    Authors: Liling Wen, Huanzi Lu, Qiusheng Li, Qunxing Li, Shuqiong Wen, Dikan Wang, Xi Wang, Juan Fang, Jun Cui, Bin Cheng and Zhi Wang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:299

    Published on:

  24. Content type: Research

    Gliomas are the most common primary tumors in central nervous system. Despite advances in diagnosis and therapy, the prognosis of glioma remains gloomy. Autophagy is a cellular catabolic process that degrades ...

    Authors: Zhi-peng Wen, Wen-jing Zeng, Yan-hong Chen, He Li, Jie-ya Wang, Quan Cheng, Jing Yu, Hong-hao Zhou, Zheng-zheng Liu, Jian Xiao and Xiao-ping Chen

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:298

    Published on:

  25. Content type: Research

    Ubiquitin-like protein 4A (UBL4A) plays a significant role in protein metabolism and the maintenance of cellular homeostasis. In cancer, UBL4A represses tumorigenesis and is involved in various signaling pathw...

    Authors: Hongze Chen, Le Li, Jisheng Hu, Zhongjie Zhao, Liang Ji, Chundong Cheng, Guangquan Zhang, Tao zhang, Yilong Li, Hua Chen, Shangha Pan and Bei Sun

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:297

    Published on:

  26. Content type: Research

    Karyopherin nuclear transport receptors play important roles in tumour development and drug resistance and have been reported as potential biomarkers and therapeutic targets for tumour treatment. However, IPO5...

    Authors: Wenjuan Zhang, Yanxia Lu, Xiaomin Li, Jianming Zhang, Weihao Lin, Wei Zhang, Lin Zheng and Xuenong Li

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:296

    Published on:

  27. Content type: Research

    High-grade endometrioid and serous endometrial cancers (ECs) are an aggressive subtype of ECs without effective therapies. The reciprocal communication between tumor cells and their surrounding microenvironmen...

    Authors: Peixin Dong, Ying Xiong, Junming Yue, Daozhi Xu, Kei Ihira, Yosuke Konno, Noriko Kobayashi, Yukiharu Todo and Hidemichi Watari

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:295

    Published on:

  28. Content type: Research

    In the era of personalized therapy, functional annotation of less frequent genetic aberrations will be instrumental in adapting effective therapeutic in clinic. Overexpression of Melanoma associated antigen A3...

    Authors: Biswajit Das and Shantibhusan Senapati

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:294

    Published on:

  29. Content type: Research

    Signal transducer and activator of transcription 3 (STAT3) is an oncogene, which upregulates in approximately 70% of human cancers. Autophagy is an evolutionarily conserved process which maintains cellular hom...

    Authors: Shichong Lin, Lehe Yang, Yulei Yao, Lingyuan Xu, Youqun Xiang, Haiyang Zhao, Liangxing Wang, Zhigui Zuo, Xiaoying Huang and Chengguang Zhao

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:293

    Published on:

  30. Content type: Research

    Bladder cancer progression has been associated with dysfunctional repair of double-strand breaks (DSB), a deleterious type of DNA lesions that fuel genomic instability. Accurate DSB repair relies on two distin...

    Authors: Christin Richter, Stephan Marquardt, Fanghua Li, Alf Spitschak, Nico Murr, Berdien A. H. Edelhäuser, George Iliakis, Brigitte M. Pützer and Stella Logotheti

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:292

    Published on:

  31. Content type: Research

    Glioma is one of the most aggressive malignant brain tumors which is characterized with highly infiltrative growth and poor prognosis. NKAP (NF-κB activating protein) is a widely expressed 415-amino acid nucle...

    Authors: Guangyan Gu, Taihong Gao, Lu Zhang, Xiuyang Chen, Qi Pang, Yanan Wang, Dan Wang, Jie Li and Qian Liu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:291

    Published on:

  32. Content type: Commentary

    This commentary wishes to highlight the latest discoveries in the mutant p53 field that have been discussed in the 8th p53 Mutant Workshop 2019, held in Lyon. TP53 mutant (mutp53) proteins are involved in the pat...

    Authors: Silvia Di Agostino, Giulia Fontemaggi, Sabrina Strano, Giovanni Blandino and Gabriella D’Orazi

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:290

    Published on:

  33. Content type: Research

    Glioblastoma (GBM) cells with stem cell-like properties are called glioma stem cells (GSCs). GSCs display highly treatment resistance and are responsible for tumor recurrence. Napabucasin (BBI608), a novel sma...

    Authors: Dongfeng Han, Tianfu Yu, Nan Dong, Bo Wang, Fei Sun and Dehua Jiang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:289

    Published on:

  34. Content type: Correction

    In the original publication of this article [1], there is a mistake in Figure 7. The tags of TGF-beta and calycosin in Western blotting electrophoresis images are reversed.

    Authors: Qun Wang, Weijun Lu, Tao Yin and Li Lu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:288

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:240

  35. Content type: Review

    Drug resistance represents the major reason of pharmacological treatment failure. It is supported by a broad spectrum of mechanisms, whose molecular bases have been frequently correlated to aberrant protein ph...

    Authors: Christian Borgo and Maria Ruzzene

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:287

    Published on:

  36. Content type: Research

    CDK5, an atypical member of the CDK family, play a significant role in the tumorigenesis of multiple organ, but CDK5 and its substrates in genesis and development of HCC is still unclear.

    Authors: Fuqiang Wang, Wenxing Zhao, Yuehong Gao, Jiechao Zhou, Huifang Li, Guanyun Zhang, Dong Guo, Chengrong Xie, Jie Li, Zhenyu Yin and Jie Zhang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:286

    Published on:

  37. Content type: Research

    Anti-angiogenic therapies demonstrate anti-tumor effects by decreasing blood supply to tumors and inhibiting tumor growth. However, anti-angiogenic therapy may leads to changes in tumor microenvironment and in...

    Authors: Weilong Zhong, Wendong Yang, Yuan Qin, Wenguang Gu, Yinyin Xue, Yuanhao Tang, Hengwei Xu, Hongzhi Wang, Chao Zhang, Changhua Wang, Bo Sun, Yanrong Liu, Huijuan Liu, Honggang Zhou, Shuang Chen, Tao Sun…

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:285

    Published on:

  38. Content type: Correction

    In the original publication of this article [1], there are two errors.

    Authors: Xihong Liu, Peiyuan Zhao, Xiujuan Wang, Lei Wang, Yingjun Zhu, Yadi Song and Wei Gao

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:284

    Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:184

  39. Content type: Research

    Mucins are key components of the mucosal barrier in the stomach that protects epithelia from carcinogenic effects of chronic inflammation. Analysis of The Cancer Genome Atlas database indicated that mucin-17 (...

    Authors: Bing Yang, Aiwen Wu, Yingqi Hu, Cuijian Tao, Ji Ming Wang, Youyong Lu and Rui Xing

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:283

    Published on:

  40. Content type: Research

    Lung cancer is the most common cause of cancer-related mortality worldwide despite diagnostic improvements and the development of targeted therapies, notably including epidermal growth factor receptor (EGFR) t...

    Authors: Yi-Ying Wu, Hung-Chang Wu, Jia-En Wu, Kuo-Yen Huang, Shuenn-Chen Yang, Si-Xuan Chen, Chao-Jung Tsao, Keng-Fu Hsu, Yuh-Ling Chen and Tse-Ming Hong

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:282

    Published on:

  41. Content type: Research

    Discoidin domain receptor-1 (DDR1) tyrosine kinase is highly expressed in a variety of human cancers and involved in various steps of tumorigenesis. However, the precise mechanisms underlying the abnormal expr...

    Authors: Sung-Tau Chou, Hsuan-Yu Peng, Kuan-Chi Mo, Yuan-Ming Hsu, Guan-Hsun Wu, Jenn-Ren Hsiao, Su-Fang Lin, Horng-Dar Wang and Shine-Gwo Shiah

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:281

    Published on:

  42. Content type: Research

    Elucidating mechanisms in oncogenes and epigenetic modifiers are needed to gain insights into the etiology and treatment of cancer, regulation of oncogene by chromatin modifiers at post-transcriptional level i...

    Authors: Rui Yang, Na Liu, Ling Chen, Yiqun Jiang, Ying Shi, Chao Mao, Yating Liu, Min Wang, Weiwei Lai, Haosheng Tang, Menghui Gao, Desheng Xiao, Xiang Wang, Fenglei Yu, Ya Cao, Qin Yan…

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:280

    Published on:

  43. Content type: Research

    A better understanding of locally advanced cervical cancer (LACC) is mandatory for further improving the rates of disease control, since a significant proportion of patients still fail to respond or undergo re...

    Authors: Marianna Buttarelli, Gabriele Babini, Giuseppina Raspaglio, Flavia Filippetti, Alessandra Battaglia, Alessandra Ciucci, Gabriella Ferrandina, Marco Petrillo, Carmela Marino, Mariateresa Mancuso, Anna Saran, Maria Elena Villani, Angiola Desiderio, Chiara D’Ambrosio, Andrea Scaloni, Giovanni Scambia…

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:279

    Published on:

  44. Content type: Research

    Partial epithelial mesenchymal transition (p-EMT) was found to play a potential role in the initial stage of metastasis in human head and neck squamous cell carcinoma (HNSCC). Some long noncoding RNAs (lncRNAs...

    Authors: Hong-Gang Xiong, Hao Li, Yao Xiao, Qi-Chao Yang, Lei-Lei Yang, Lei Chen, Lin-Lin Bu, Wen-Feng Zhang, Jia-Li Zhang and Zhi-Jun Sun

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:278

    Published on:

  45. Content type: Research

    The deubiquitinating enzyme ubiquitin-specific protease 3 (USP3) plays a crucial role in numerous biological processes. The aberrant expression of USP3 may have an important role in tumor development. However,...

    Authors: Xiaosheng Wu, Mengwei Liu, Huiqiong Zhu, Jing Wang, Weiyu Dai, Jiaying Li, Danping Zhu, Weimei Tang, Yizhi Xiao, Jianjiao Lin, Wenjing Zhang, Yong Sun, Yi Zhang, Yaying Chen, Guoxin Li, Aimin Li…

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:277

    Published on:

  46. Content type: Research

    The E2A gene, which encodes two basic helix–loop–helix transcription factors, E12 and E47, regulates colorectal cancer progression and epithelial-mesenchymal transition. However, whether E2A regulates the tumo...

    Authors: Hongchao Zhao, Chunlin Zhao, Haohao Li, Danhua Zhang and Guanghui Liu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:276

    Published on:

  47. Content type: Research

    The current chemotherapy regimens may extend survival for patients with metastatic bladder cancer (BCa) for a few months, but eventually most patients succumb to disease because they develop resistance to thei...

    Authors: Chi-Ping Huang, Jinbo Chen, Chi-Cheng Chen, Guodong Liu, Yong Zhang, Edward Messing, Shuyuan Yeh and Chawnshang Chang

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:275

    Published on:

  48. Content type: Research

    Local resident normal fibroblasts (NFs) are the major source of cancer-associated fibroblasts (CAFs), which are distinguishable from NFs by their tumor-supportive properties. However, the mechanism and the eff...

    Authors: Yujia Wang, Yue Jing, Liang Ding, Xiaoxin Zhang, Yuxian Song, Sheng Chen, Xingxing Zhao, Xiaofeng Huang, Yumei Pu, Zhiyong Wang, Yanhong Ni and Qingang Hu

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:274

    Published on:

  49. Content type: Research

    DEPTOR is an endogenous inhibitor of mTORC1 and mTORC2 that plays a vital role in the progression of human malignances. However, the biological function of DEPTOR in HCC metastasis and the underlying molecular...

    Authors: Jin Chen, Haidan Zhu, Qiumeng Liu, Deng Ning, Zhaoqi Zhang, Long Zhang, Jie Mo, Pengcheng Du, Xu Liu, Shasha Song, Yawei Fan, Huifang Liang, Jikui Liu, Bixiang Zhang and Xiaoping Chen

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:273

    Published on:

  50. Content type: Research

    Development of resistance to inhibitors of BRAF (BRAFi) and MEK (MEKi) remains a great challenge for targeted therapy in patients with BRAF-mutant melanoma. Here, we explored the role of miRNAs in melanoma acq...

    Authors: Simona Caporali, Adriana Amaro, Lauretta Levati, Ester Alvino, Pedro Miguel Lacal, Simona Mastroeni, Federica Ruffini, Laura Bonmassar, Gian Carlo Antonini Cappellini, Nadia Felli, Alessandra Carè, Ulrich Pfeffer and Stefania D’Atri

    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:272

    Published on:

Follow

Annual Journal Metrics

Advertisement

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us